Impact of Tumour Genomics on Response to standard Neo-adjuvant Chemotherapy in Triple Negative Breast Cancer, Integrative co-expression network analysis of mRNA and miRNA profile identifies miRNA 664 as an inhibitor of key genes in Triple negative breast cancer